Risultati della ricerca - Edelgard Lindhoff‐Last

  • Mostra 1 - 12 risultati su 12
Raffina i risultati
  1. 1
    New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness

    New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness di Helen Mani, Edelgard Lindhoff‐Last

    Pubblicazione 2014
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    Treatment of 51 pregnancies with danaparoid because of heparin intolerance

    Treatment of 51 pregnancies with danaparoid because of heparin intolerance di Hans-Joachim Kreutzenbeck, Harry Magnani, Edelgard Lindhoff‐Last

    Pubblicazione 2004
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    Laboratory testing of rivaroxaban in routine clinical practice: When, how, and which assays

    Laboratory testing of rivaroxaban in routine clinical practice: When, how, and which assays di Edelgard Lindhoff‐Last, Jack Ansell, Theodore E. Spiro, M Samama

    Pubblicazione 2013
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  4. 4
    Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements

    Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements di H. Mani, Beate Luxembourg, Christina Kläffling, M. Erbe, Edelgard Lindhoff‐Last

    Pubblicazione 2005
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Incidence and clinical relevance of heparin‐induced antibodies in patients with deep vein thrombosis treated with unfractionated or low‐molecular‐weight heparin

    Incidence and clinical relevance of heparin‐induced antibodies in patients with deep vein thrombosis treated with unfractionated or low‐molecular‐weight heparin di Edelgard Lindhoff‐Last, Roumen Nakov, Frank Misselwitz, Hans‐Klaus Breddin, Rupert Bauersachs

    Pubblicazione 2002
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Incidence and causes of heparin-induced skin lesions

    Incidence and causes of heparin-induced skin lesions di Marc Schindewolf, Sandra L. Schwaner, Manfred Wolter, H. Kroll, Andreas Recke, R. Kaufmann, Wolf‐­Henning Boehncke, Edelgard Lindhoff‐Last, Ralf J. Ludwig

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia

    Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia di Dirk Walter, Hans Krankenberg, Jörn O. Balzer, Christoph Kalka, Iris Baumgärtner, Michael Schlüter, Torsten Tonn, Florian Seeger, Stefanie Dimmeler, Edelgard Lindhoff‐Last, Andreas M. Zeiher

    Pubblicazione 2011
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

    International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants di Robert C. Gosselin, Dorothy M. Adcock, Shannon M. Bates, Jonathan Douxfils, Emmanuel J. Favaloro, Isabelle Gouin‐Thibault, Cecilia Guillermo, Yohko Kawai, Edelgard Lindhoff‐Last, Steve Kitchen

    Pubblicazione 2018
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

    2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants di Jonathan Douxfils, Dorothy M. Adcock, Shannon M. Bates, Emmanuel J. Favaloro, Isabelle Gouin‐Thibault, Cecilia Guillermo, Yohko Kawai, Edelgard Lindhoff‐Last, Steve Kitchen, Robert C. Gosselin

    Pubblicazione 2021
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  10. 10
    Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis

    Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis di Linda Schönborn, Sabrina E. Seck, Thomas Thiele, Lars Kaderali, Till Hoffmann, A Hlinka, Edelgard Lindhoff‐Last, Uwe Völker, Kathleen Selleng, Alessandra Buoninfante, Marco Cavaleri, Andreas Greinacher

    Pubblicazione 2023
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia

    Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia di Marc Schindewolf, Julia Steindl, Jan Beyer‐Westendorf, Sebastian Schellong, Pascal M. Dohmen, Johannes Brachmann, Katharina Madlener, Bernd Pötzsch, Robert Klamroth, Johannes Hankowitz, Norbert Banik, Sonja Eberle, Markus Müller, Stefan Kropff, Edelgard Lindhoff‐Last

    Pubblicazione 2017
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure

    Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure di Linda Schönborn, Olga Esteban, Jan Wesche, Paulina Dobosz, Marta Broto, Sara Rovira Puig, Jessica Fuhrmann, Raquel Torres, Josep Serra, Roser Llevadot, Marta Palicio, Jing Jing Wang, Tom P. Gordon, Edelgard Lindhoff‐Last, Till Hoffmann, Lorenzo Alberio, Florian Länger, Christian Boehme, Eugenia Biguzzi, Leonie Grosse, Matthias Endres, Thomas Liman, Thomas Thiele, Theodore E. Warkentin, Andreas Greinacher

    Pubblicazione 2023
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: